CAR-T Cell Therapy

Chimeric antigen receptor T cell therapy (CAR-T) is a new treatment for certain types of blood cancers that uses a person’s own immune cells (T cells) to try to destroy cancer cells.

CAR-T therapy is publicly funded for specific indications and can also be accessed through clinical trials for some patient groups. Learn more about CAR-T therapy for your patients.

We accept referrals for patients with B-cell Lymphoma and B-Precursor Acute-Lymphoblastic Leukaemia/Lymphoma. Learn more about the eligibility criteria and our referral process.